MENU
+Compare
PBSV
Stock ticker: OTC
AS OF
Aug 15 closing price
Price
$0.60
Change
+$0.09 (+17.65%)
Capitalization
13.76M

PBSV stock forecast, quote, news & analysis

Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm... Show more

PBSV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PBSV showed earnings on June 16, 2025. You can read more about the earnings report here.
Interact to see
Advertisement
A.I.Advisor
a Summary for PBSV with price predictions
Aug 15, 2025

PBSV in upward trend: price may jump up because it broke its lower Bollinger Band on August 14, 2025

PBSV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 41 cases where PBSV's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PBSV's RSI Indicator exited the oversold zone, of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on August 15, 2025. You may want to consider a long position or call options on PBSV as a result. In of 150 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

PBSV moved above its 50-day moving average on August 15, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where PBSV advanced for three days, in of 81 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 92 cases where PBSV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for PBSV turned negative on July 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 77 similar instances when the indicator turned negative. In of the 77 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PBSV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.135) is normal, around the industry mean (10.946). P/E Ratio (20.231) is within average values for comparable stocks, (80.862). PBSV's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.386). Dividend Yield (0.000) settles around the average of (0.063) among similar stocks. P/S Ratio (1.429) is also within normal values, averaging (86.429).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PBSV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
published Dividends

PBSV paid dividends on March 20, 2025

Pharma-Bio Serv, Inc. PBSV Stock Dividends
А quarterly dividend of $0.08 per share was paid with a record date of March 20, 2025, and an ex-dividend date of February 28, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 2.19B. The market cap for tickers in the group ranges from 52.04K to 45.86B. VEEV holds the highest valuation in this group at 45.86B. The lowest valued company is PPRG at 52.04K.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was 1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 3%. DTRK experienced the highest price growth at 37%, while VSEE experienced the biggest fall at -41%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -26%. For the same stocks of the Industry, the average monthly volume growth was 11% and the average quarterly volume growth was -16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 72
Price Growth Rating: 61
SMR Rating: 85
Profit Risk Rating: 94
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
PBSV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry ServicestotheHealthIndustry

Profile
Fundamentals
Details
Industry
N/A
Address
No. 6 Road 696
Phone
+1 787 278-2709
Employees
100
Web
https://www.pharmabioserv.com